These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Livedo reticularis associated with rasagiline (azilect). Strowd LC; Lee AD; Yosipovitch G J Drugs Dermatol; 2012 Jun; 11(6):764-5. PubMed ID: 22648227 [TBL] [Abstract][Full Text] [Related]
4. Drug-induced acute pancreatitis: a rare manifestation of an incomplete "dapsone syndrome". Das AK; Jawed Q Indian J Pharmacol; 2014; 46(4):455-7. PubMed ID: 25097293 [TBL] [Abstract][Full Text] [Related]
5. Case for diagnosis. Silva SB; Miot HA An Bras Dermatol; 2012; 87(2):319-21. PubMed ID: 22570045 [TBL] [Abstract][Full Text] [Related]
6. Interferons beta have vasoconstrictive and procoagulant effects: a woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis. Rot U; Ledinek AH Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S79-81. PubMed ID: 24321162 [TBL] [Abstract][Full Text] [Related]
7. Treatment of peristomal pyoderma gangrenosum with topical crushed dapsone. Handler MZ; Hamilton H; Aires D J Drugs Dermatol; 2011 Sep; 10(9):1059-61. PubMed ID: 22052278 [TBL] [Abstract][Full Text] [Related]
8. Dapsone and sulfapyridine. Paniker U; Levine N Dermatol Clin; 2001 Jan; 19(1):79-86, viii. PubMed ID: 11155588 [TBL] [Abstract][Full Text] [Related]
9. Amantadine-Induced Livedo Racemosa. Criado PR; Alavi A; Valente NY; Sotto MN Int J Low Extrem Wounds; 2016 Mar; 15(1):78-81. PubMed ID: 26338517 [TBL] [Abstract][Full Text] [Related]
10. Amantadine-induced livedo reticularis--Case report. Quaresma MV; Gomes AC; Serruya A; Vendramini DL; Braga L; Buçard AM An Bras Dermatol; 2015; 90(5):745-7. PubMed ID: 26560223 [TBL] [Abstract][Full Text] [Related]
11. Alternative procedure to allow continuation of dapsone therapy despite serious adverse reaction in a case of dapsone-sensitive erythema elevatum diutinum. Seneschal J; Guillet S; Ezzedine K; Taïeb A; Milpied B Dermatology; 2012; 224(2):115-9. PubMed ID: 22508198 [TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity in HIV-infected patients switched from trimethoprim-sulfamethoxazole to dapsone. Holtzer CD; Flaherty JF; Coleman RL Pharmacotherapy; 1998; 18(4):831-5. PubMed ID: 9692656 [TBL] [Abstract][Full Text] [Related]
13. Asymptomatic dapsone-induced agranulocytosis in a patient with chronic spontaneous urticaria. Milkova L; Hallermann C; Simon JC; Treudler R J Dtsch Dermatol Ges; 2014 Aug; 12(8):717-9. PubMed ID: 24981604 [No Abstract] [Full Text] [Related]
14. Livedo reticularis heralding hypercalcaemia of malignancy. Sundriyal D; Kumar N; Kumar G; Walia M BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24832704 [TBL] [Abstract][Full Text] [Related]
15. Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole. Beumont MG; Graziani A; Ubel PA; MacGregor RR Am J Med; 1996 Jun; 100(6):611-6. PubMed ID: 8678080 [TBL] [Abstract][Full Text] [Related]
16. A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis. Leslie KS; Gaffney K; Ross CN; Ridley S; Barker TH; Garioch JJ Clin Exp Dermatol; 2003 Sep; 28(5):496-8. PubMed ID: 12950336 [TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment of livedo reticularis on the legs]. Herrero C; Guilabert A; Mascaró-Galy JM Actas Dermosifiliogr; 2008 Oct; 99(8):598-607. PubMed ID: 19080891 [TBL] [Abstract][Full Text] [Related]
18. Livedo reticularis after intra-articular hyaluronic acid injection. de Azevedo Campos SL; Brasileiro A; João A; Lopes MJP Indian J Dermatol Venereol Leprol; 2017; 83(5):602-603. PubMed ID: 28731012 [No Abstract] [Full Text] [Related]